Short Summary
The Gujarat High Court disposed of a writ petition filed by M/S. Liladhar Indarji And Co. challenging the rejection of its trademark renewal applications (No. 1502218 and 1502220). Instead of ruling on the merits of the initial rejection, the court granted the petitioner liberty to file a fresh application for renewal. The respondent authority agreed that if the petitioner submits a new request with all prescribed fees, it will be considered within four weeks.
Detailed Summary
Every founder knows that registering a trademark is only half the battle—keeping it alive through timely renewals is where many businesses quietly lose their rights. But what happens when the renewal itself is rejected, and the clock is ticking? The case of M/S. Liladhar Indarji And Co. versus the Union of India offers a fascinating look at how courts sometimes choose pragmatism over principle, giving petitioners a second shot rather than a definitive ruling.
M/S. Liladhar Indarji And Co., a business entity, found itself in a difficult spot when its trademark renewal applications—bearing numbers 1502218 and 1502220—were rejected by the relevant authority. Rather than accept the rejection quietly, the company approached the Gujarat High Court by way of a writ petition, challenging the decision of the respondent, the Union of India. The dispute centered squarely on the procedural and administrative handling of trademark renewals, a routine yet high-stakes process for any business that relies on its brand identity.
On one side, the petitioner argued that the rejection of its renewal applications was unjustified and sought judicial intervention to overturn the decision. On the other side stood the Union of India, representing the administrative machinery responsible for processing trademark renewals. The legal friction here was not about whether the trademark was valid or distinctive—it was about whether the rejection itself could withstand scrutiny, or whether the petitioner deserved another opportunity to get its paperwork right.
Rather than diving into the merits of why the original renewal applications were rejected, the Gujarat High Court took a pragmatic route. The court disposed of the writ petition by granting the petitioner liberty to file a fresh application for renewal. Crucially, the respondent authority agreed to this arrangement, committing that if the petitioner submitted a new request along with all prescribed fees, the application would be considered and processed within four weeks. The outcome was mixed in character: the petitioner did not win a ruling on the merits of the original rejection, but it walked away with something arguably more valuable—a clean slate and a guaranteed timeline for reconsideration.
For founders and IP professionals, this case carries a clear practical lesson: when facing administrative rejections on procedural grounds—such as missing fees, incomplete forms, or technical errors in trademark renewals—the fastest path forward may not be a full-blown legal battle over the rejection itself. Courts are often willing to grant liberty to reapply, provided the respondent authority cooperates. The smart move is to prepare a fresh, fully compliant application alongside any legal challenge, so that if the court offers a procedural reset, you are ready to act immediately and protect your brand without losing momentum.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in trademark matters before Gujarat High Court. Understanding the court's reasoning in M/S. Liladhar Indarji And Co. vs Union Of India is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Applicant/Plaintiff (Name not specified)vsM/S.Knoll Health Care Pvt. Ltd.
The Madras High Court addressed an application filed by the plaintiff seeking permission to initiate fresh trademark rectification proceedings against a registered mark held by the respondent. The court noted that multiple rectification actions were already pending before the Registrar and other forums initiated by both parties. Consequently, the court rejected the plaintiff's request for leave, emphasizing that existing legal processes must be allowed to run their course to prevent conflicting judgments.
M/s.Bahwan Cyber Tek Pvt. Ltd.vsAptivaa Consulting Solutions Private Limited
The Madras High Court formally accepted a Joint Memo of Compromise between M/s.Bahwan Cyber Tek Pvt. Ltd. and its defendants regarding trademark infringement concerning 'ASYMMETRIX EARLY WARNING SYSTEM'. The parties agreed that the defendants would cease all use, display, or advertising of the disputed mark in relation to software products. In exchange, the plaintiff waived most other reliefs sought in the suit, leading the court to decree the case based on the terms of the compromise.
Novartis Ag & Anr.vsNovarise Pharmachem Private Limited
The Delhi High Court granted an ad-interim injunction in favor of Novartis against Novarise Pharmachem Private Limited, addressing a trademark infringement dispute. The court found that the Plaintiffs had established a prima facie case regarding their registered trade mark 'NOVARTIS,' noting its extensive use and high goodwill in the pharmaceutical sector. Given the likelihood of consumer confusion between 'NOVARTIS' and 'NOVARISE,' the court restrained the defendant from manufacturing or selling products under the impugned mark until further hearing.
Montblanc-Simplo GmbhvsMs. Jasmin Chandrakant Vora & Ors.
In this trademark infringement suit, Montblanc-Simplo Gmbh sought permanent injunctions and damages against the defendants for using its registered trademarks and devices. The court noted the parties' initial request for exemption from mediation but ultimately referred them to pre-litigation mediation. Subsequently, the defendants assured the court that they would withdraw infringing products from e-commerce sites within a week and were granted time to file an undertaking confirming their non-infringement intentions.
cipla health limitedvssyndicate pharma anr
Cipla Health Limited (formerly Cipla Limited) sued Syndicate Pharma and another for infringement of its trademark 'OMNIGEL' and trade dress, alleging the defendants were using a nearly identical mark 'ONMIGEL' on pain relief ointments. The plaintiff claimed extensive prior use since 2000 and significant sales revenue (INR 231 crores in FY 2023-24), arguing the defendant’s actions constituted passing off, dilution, copyright infringement, and misrepresentation.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.